Fully Human Therapeutic mAb Discovery

Fully Human Therapeutic mAb Discovery

ChemPartner’s proprietary fully human naïve phage library with diversity ~10^11. Efficient library selection and screening with high-throughput robotics. All V-genes were amplified with high fidelity from diverse healthy donors. Stringent cloning procedures ensure a...
Fully Human Therapeutic mAb Discovery

Key Technologies

Specific Pathogen Free (SPF) animals and multiple species/strains such as SJL mice and SD rats New Zealand White rabbit are available for immune phage library approach Animal strains with superior immune response to highly conserved and multi-transmembrane protein...
Fully Human Therapeutic mAb Discovery

Featured Services

Immunogen and Antigen Preparation Recombinant protein production and cell line development Peptide and compound design and synthesis DNA In vivo transfection Binding Assays and Bioassays Well-established assays Assay development and optimization for hybridoma...
Fully Human Therapeutic mAb Discovery

Antibody-Drug Conjugate (ADC)

ChemPartner has a top-tier antibody drug conjugate (ADC) team spanning multiple areas, such as antibody development, medicinal chemistry, DMPK, and in vitro/in vivo pharmacology. In addition to individual function service packages, ChemPartner also provides all-in-one...
Fully Human Therapeutic mAb Discovery

Phage Display

ChemPartner’s phage display and high throughput screening group offers streamlined services for fully human therapeutic antibody discovery and optimization, also providing coherent protein engineering, immune library construction, and screening for general biologics...